Best Practice & Research Clinical Rheumatology
Volume 20, Issue 6 , Pages 1159-1179, December 2006

Rheumatologic complications of HIV infection

  • John D. Reveille, MD (Professor and Director)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 713 500 6900; Fax: +1 713 500 0523.

The University of Texas-Houston Health Science Center, MSB 5.270, 6431 Fannin, Houston, TX77030, USA

Diagnostic Clinic of Houston, Houston, TX77005, USA

The pandemic caused by the human immunodeficiency virus (HIV) has entered its second quarter-century, with 40 million people now affected worldwide – particularly in Africa, where the impact has been most devastating. A complex array of rheumatic disease manifestations has been described, including diseases specific to HIV infection such as HIV-associated arthritis and the diffuse infiltrative lymphocytosis syndrome; other conditions which occur prominently in HIV-positive individuals include vasculitis, reactive and psoriatic arthritis and HIV-associated polymyositis, opportunistic musculoskeletal infections, and finally disorders that were originally ameliorated by HIV infection, such as rheumatoid arthritis and lupus. Effective antiretroviral treatment ameliorates many of these disorders; however, the introduction of highly active antiretroviral treatment (HAART) has introduced a new spectrum of disorders and new challenges confronting the clinician, including osteonecrosis, rhabdomyolysis, and, with immune reconstitution, the appearance de novo of a variety of autoimmune disorders and phenomena.

Key words: HIV infection, reactive arthritis, DILS, HIV arthritis, HIV-associated polymyositis, HAART, immune reconstitution syndrome

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6942(06)00119-7

doi:10.1016/j.berh.2006.08.015

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 6 , Pages 1159-1179, December 2006